ARTICLE | Company News
Rigel, Novartis begin angiogenesis project
July 31, 2001 7:00 AM UTC
Under a 1999 deal, the companies will research and develop small molecule compounds that inhibit angiogenesis for cancer therapy. The start of the project triggered a $4 million cash payment to RIGL, ...